J.M. Extra - Concepedia

Author

J.M. Extra

Hôpital Saint-Louis

Also Known As

Extra, J. M., J EXTRA, J Extra, J M Extra, J-M Extra, J-M. Extra, J. M. EXTRA, J. M. Extra, J.-M. Extra, J.M Extra

Publications

746

Citations

H-Index

Concepts

All Affiliations

Hôpital Saint-Louis Université Paris Cité Institut Paoli-Calmettes

About

J.M. Extra is an author at Hôpital Saint-Louis specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	382
2	Pharmacology	3	3	102
3	Health Sciences	2	2	47
4	Pathology	2	2	90
5	Marrow Transplantation	1	1	17

J.M. Extra

Publications

551

Citations

H-Index

Page 1

	Year	Citations
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial Xavier Pivot, Gilles Romieu, Marc Debled, The Lancet Breast OncologyOncologyEarly Breast CancerRandomised TrialBreast Cancer	2019	125
p53 mutations and overexpression in locally advanced breast cancers A Faille, Patricia de Crémoux, J.M. Extra, British Journal of Cancer Breast OncologyP53 MutationsMedicineCancer GenomicsBreast Cancer	1994	72
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). Bertrand Coiffier, P.A. Bryon, F Berger, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyImmunotherapyHematological Malignancy	1986	71
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. Véronique Dièras, J.M. Extra, Éric Bellissant, Journal of Clinical Oncology	1996	69
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. P. Fumoleau, T. Delozier, J.M. Extra, PubMed	1995	43
Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy J.-P. Ménard, J.M. Extra, J Jacquemier, European Journal of Surgical Oncology Surgical OncologyBreast OncologyNeoadjuvant ChemotherapySentinel LymphadenectomyMedicine	2009	37
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen Sylvie Giacchetti, Raphaël Porcher, Anne‐Sophie Hamy, British Journal of Cancer	2014	30
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. Christian Gisselbrecht, J.M. Extra, JP Lotz, PubMed	1996	27
Trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone as first-line treatment of HER2-positive metastatic breast cancer (MBC): results of a randomised multicentre trial J.M. Extra, F. Cognetti, D Maranichi, European Journal of Cancer Supplements Breast OncologyOncologyPharmacologyClinical TrialsDocetaxel Versus Docetaxel	2004	21
Non-Hodgkin's lymphoma with cardiac presentation: evaluation and follow-up with echocardiography and MR imaging Jean-Jacques Monsuez, J Frija, Lucie Hertz‐Pannier, European Heart Journal Lymphoid NeoplasiaImproved PrognosisPathologyCardiac PresentationMr Imaging	1991	19

Page 1